AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TOCILIZUMAB
31 registrations across 7 African markets— 30 active
Markets with TOCILIZUMAB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ACTEMRA 80MG Solution For Infusion | 🇰🇪Kenya | F. HOFFMAN-LA ROCHE LTD | active | Jul 2031 |
| ACTEMRA 400MG Solution For Infusion | 🇰🇪Kenya | F. HOFFMAN-LA ROCHE LTD | active | Jul 2031 |
| ACTEMRA Solution injectable / 162 mg/0.9 ml | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Aug 2019 |
| ACTEMRA 200 | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| ACTEMRA 80 | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| ACTEMRA 400 | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| ACTEMRA SC | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| ACTEMRA 400MG/20ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ACTEMRA 200MG/10ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ACTEMRA AMPOULE / 200MG/10ML | 🇸🇳Senegal | ROCHE | active | — |
| RoActemra solution a diluer pour perfusion / 200 mg | 🇸🇳Senegal | — | active | — |
| ACTEMRA solution pour perfusion / 200 mg / 20 ml ml | 🇸🇳Senegal | ROCHE PHARMA SA | active | — |
| ACTEMRA 80MG/4ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ACTEMRA AMPOULE / 80MG/4ML | 🇸🇳Senegal | ROCHE | active | — |
| Actemra 200 mg Concentrate for solution for infusion | 🇳🇬Nigeria | — | active | — |
| Tocilizumab Concentrate for solution for infusion 20mg/ml (Each vial contains 400 mg of tocilizumab in 20 mL) Concentrate for solution for infusion | 🌍WW | Roche Registration GmbH | active | — |
| Actemra 400 mg Concentrate for solution for infusion | 🇳🇬Nigeria | — | active | — |
| Actemra 162 mg Solution for injection | 🇳🇬Nigeria | — | active | — |
| RoActemra solution a diluer pour perfusion / 80 mg | 🇸🇳Senegal | — | active | — |
| Tocilizumab Concentrate for solution for infusion 20mg/ml (Each vial contains 80 mg of tocilizumab in 4 mL) Concentrate for solution for infusion | 🌍WW | Roche Registration GmbH | active | — |
| Tocilizumab Concentrate for solution for infusion 20mg/ml (Each vial contains 200 mg of tocilizumab in 10 mL) Concentrate for solution for infusion | 🌍WW | Roche Registration GmbH | active | — |
| RoActemra solution a diluer pour perfusion / 400 mg | 🇸🇳Senegal | — | active | — |
| ACTEMRA AMPOULE / 80MG/4ML | 🇸🇳Senegal | ROCHE | active | — |
| ACTEMRA AMPOULE / 200MG/10ML | 🇸🇳Senegal | ROCHE | active | — |
| ACTEMRA AMPOULE / 400MG/ 20ML | 🇸🇳Senegal | ROCHE | active | — |
| RoActemra solution a diluer pour perfusion / 80 mg | 🇸🇳Senegal | — | active | — |
| RoActemra solution a diluer pour perfusion / 200 mg | 🇸🇳Senegal | — | active | — |
| RoActemra solution a diluer pour perfusion / 400 mg | 🇸🇳Senegal | — | active | — |
| ACTEMRA solution pour perfusion / 80 mg / 20 ml | 🇸🇳Senegal | ROCHE PHARMA SA | active | — |
| ACTEMRA AMPOULE / 400MG/ 20ML | 🇸🇳Senegal | ROCHE | active | — |
| Actemra 80 mg Concentrate for solution for infusion | 🇳🇬Nigeria | — | active | — |
TOCILIZUMAB in Africa — Regulatory Overview
TOCILIZUMAB is registered across 7 African markets with 31 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Nigeria, South Africa, Morocco and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 31 registrations, 30 (97%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.